UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.29 -2.64 (-3.22%) GOLD FUTURES
2,316.20 +13.30 (+0.58%) DOW
37,937.31 +121.39 (+0.32%) Bitcoin GBP
45,627.84 -2,705.49 (-5.60%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:46PM EDT. Market open.
| Previous close | 6.05 |
| Open | 6.01 |
| Bid | 6.05 x 200 |
| Ask | 6.10 x 200 |
| Day's range | 6.01 - 6.19 |
| 52-week range | 1.74 - 6.46 |
| Volume | |
| Avg. volume | 1,574,906 |
| Market cap | 1.868B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.48 |
| Earnings date | 29 Feb 2024 - 04 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.25 |
Business WireAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Business WireAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Simply Wall St.Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
© 2024 Yahoo. All rights reserved.